TRIP Expands Night-Time Portfolio with CBD-Free Sleep Range

Why It Matters

By expanding into the fast‑growing sleep‑supplement segment, TRIP can capture consumers seeking non‑CBD, plant‑based solutions and deepen brand loyalty through the Calm partnership. The move underscores the broader market shift toward holistic, routine‑based sleep aids.

Key Takeaways

• TRIP launches CBD‑free Dream Blend gummies and powder for sleep.
• Products include magnesium, chamomile, valerian, and other plant‑based ingredients.
• Each purchase includes a three‑month premium Calm app membership.
• Sleep supplement market projected to grow to $11.8 B by 2034.
• Campaign slogan “Dream Better to Dream Bigger” promotes nightly ritual.

Pulse Analysis

The sleep‑supplement sector is experiencing a surge, driven by heightened awareness of sleep’s role in overall health and by regulatory constraints on traditional aids like melatonin in markets such as the UK. Allied Market Research estimates the industry will swell from roughly $6.8 billion today to $11.8 billion by 2034, a trajectory fueled by the 40 % of adults who report chronic sleep difficulties. This macro trend creates fertile ground for brands that can offer scientifically backed, non‑pharmaceutical alternatives.

TRIP’s entry with Dream Blend leverages both format diversity and ingredient transparency. By offering gummies for convenience and a powder for ritualized preparation, the brand addresses distinct consumer moments—on‑the‑go versus deliberate wind‑down. The ingredient roster—magnesium, chamomile, valerian, tart cherry, L‑theanine, and others—aligns with the most searched sleep‑support compounds, including a 44 % year‑over‑year rise in magnesium glycinate queries. Plant‑based, low‑sugar formulations further differentiate TRIP in a crowded shelf, appealing to health‑conscious shoppers wary of artificial additives.

Marketing-wise, the partnership with Calm and the “Dream Better to Dream Bigger” campaign embed the products within a broader wellness ecosystem. The three‑month premium Calm membership adds digital value, encouraging users to integrate meditation and sleep tracking with the physical supplement. This cross‑channel strategy not only drives initial trial but also fosters habit formation, positioning TRIP for repeat purchases as consumers embed the ritual into nightly routines. As the sleep‑health narrative gains momentum, brands that combine evidence‑based ingredients with lifestyle‑centric experiences are poised to capture a larger share of the expanding market.